KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy

被引：0
|
作者：
Lakmini Mudduwa
Harshini Peiris
Shania Gunasekara
Deepthika Abeysiriwardhana
Nimsha Liyanage
Suresh K. Rayala
Thusharie Liyanage
机构：
[1] University of Ruhuna,Department of Pathology, Faculty of Medicine
[2] University of Ruhuna,Medical Laboratory Science Degree Programme, Faculty of Medicine
[3] Indian Institute of Technology Madras (IITM),Department of Biotechnology
来源：
BMC Cancer | / 18卷
关键词：
ER; Endocrine therapy; Breast cancer; KIBRA; Recurrence free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Quality of life assessment in patients receiving adjuvant therapy for breast cancer: The IBCSG approach
    Bernhard, J
    Hurny, C
    Coates, AS
    Peterson, HF
    CastiglioneGertsch, M
    Gelber, RD
    Goldhirsch, A
    Senn, HJ
    Rudenstam, CM
    ANNALS OF ONCOLOGY, 1997, 8 (09) : 825 - 835
  • [22] Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy
    Solai Elango Damodaran
    Suresh Chandra Pradhan
    Gurusamy Umamaheswaran
    Dharanipragada Kadambari
    K. Sathyanarayana Reddy
    Chandrasekaran Adithan
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 75 - 81
  • [23] Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy
    Damodaran, Solai Elango
    Pradhan, Suresh Chandra
    Umamaheswaran, Gurusamy
    Kadambari, Dharanipragada
    Reddy, K. Sathyanarayana
    Adithan, Chandrasekaran
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 75 - 81
  • [24] Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy
    David Cella
    Lesley J. Fallowfield
    Breast Cancer Research and Treatment, 2008, 107 : 167 - 180
  • [25] Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy
    Cella, David
    Fallowfield, Lesley J.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 107 (02) : 167 - 180
  • [26] Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer
    Corter, Arden L.
    Broom, Reuben
    Porter, David
    Harvey, Vernon
    Findlay, Michael
    PSYCHO-ONCOLOGY, 2018, 27 (09) : 2096 - 2103
  • [27] Establishing nomograms for predicting disease-free survival and overall survival in patients with breast cancer
    Zhou, Ling
    Bai, Lifen
    Zhu, Huiyin
    Guo, Chongyong
    Liu, Sheng
    Yin, Lu
    Sun, Jian
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 44 (01)
  • [28] Development and validation of a novel nomogram for predicting distant metastasis-free survival among breast cancer patients
    Wang, Yan
    Yang, Yaping
    Chen, Zhengbo
    Zhu, Teng
    Wu, Jiannan
    Su, Fengxi
    Deng, Heran
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (20)
  • [29] Predicting Adherence to Tamoxifen for Breast Cancer Adjuvant Therapy and Prevention
    Lin, Jennifer H.
    Zhang, Shumin M.
    Manson, JoAnn E.
    CANCER PREVENTION RESEARCH, 2011, 4 (09) : 1360 - 1365
  • [30] Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk
    Onwudiwe, Nneka C.
    Kwok, Young
    Onukwugha, Eberechukwu
    Sorkin, John D.
    Zuckerman, Ilene H.
    Shaya, Fadia T.
    Mullins, C. Daniel
    CANCER MEDICINE, 2014, 3 (05): : 1342 - 1352
12345